Chemical tuning of photoswitchable azobenzenes: a photopharmacological case study using nicotinic transmission

• Lorenzo Sansalone,
• Jun Zhao,
• Matthew T. Richers and
• Graham C. R. Ellis-Davies

Beilstein J. Org. Chem. 2019, 15, 2812–2821, doi:10.3762/bjoc.15.274

• fundamentally different categories which were defined, historically, using pharmacology. The neurotransmitter-gated ion channels are activated by the drug nicotine, and these are called nicotinic (n)AChR. The G-protein-coupled receptors are activated by the drug muscarine, and these are called muscarinic (m

A toolbox of molecular photoswitches to modulate the CXCR3 chemokine receptor with light

• Xavier Gómez-Santacana,
• Sabrina M. de Munnik,
• Tamara A. M. Mocking,
• Niels J. Hauwert,
• Shanliang Sun,
• Prashanna Vijayachandran,
• Iwan J. P. de Esch,
• Henry F. Vischer,
• Maikel Wijtmans and
• Rob Leurs

Beilstein J. Org. Chem. 2019, 15, 2509–2523, doi:10.3762/bjoc.15.244

• full agonism. The compound class disclosed here can aid in new photopharmacology studies of CXCR3 signaling. Keywords: azo compounds; chemokine receptor; efficacy photoswitching; G protein-coupled receptors; photopharmacology; Introduction Photopharmacology is an emerging discipline at the interface

• activity and physiological events with light. A number of protein targets have been explored with photochromic small-molecule ligands, such as ion channels, microtubules, enzymes and GPCRs (G protein-coupled receptors) [1][10]. We focus our photopharmacology research on GPCRs [3][7][11], which constitute a

Azologization of serotonin 5-HT₃ receptor antagonists

• Karin Rustler,
• Galyna Maleeva,
• Piotr Bregestovski and
• Burkhard König

Beilstein J. Org. Chem. 2019, 15, 780–788, doi:10.3762/bjoc.15.74

• receptor, while the other six members are G protein-coupled receptors (GPCRs). The 5-HT3 receptor is related to chemo-/radiotherapy provoked emesis and dysfunction leads to neurodevelopmental disorders and psychopathologies. Since the development of the first serotonin receptor antagonist in the early

• developmental stages my lead to altered cognitive ability, neurodevelopmental disorders, and increased incidence of psychopathologies such as autism and schizophrenia [15][16]. Serotonin operates via seven classes of 5-HT receptors of which six are G protein-coupled receptors (GPCRs) and only one, the 5-HT3R

Synthesis of a tubugi-1-toxin conjugate by a modulizable disulfide linker system with a neuropeptide Y analogue showing selectivity for hY1R-overexpressing tumor cells

• Rainer Kufka,
• Robert Rennert,
• Goran N. Kaluđerović,
• Lutz Weber,
• Wolfgang Richter and
• Ludger A. Wessjohann

Beilstein J. Org. Chem. 2019, 15, 96–105, doi:10.3762/bjoc.15.11

• targeting of the conjugate towards a specific molecular structure that has been identified to be characteristic for a diseased state of cells and tissues. Particularly G protein-coupled receptors (GPCRs) that are endogenously activated by agonistic peptide or protein ligands can be suitable target

G-Protein coupled receptors: answers from simulations

• Timothy Clark

Beilstein J. Org. Chem. 2017, 13, 1071–1078, doi:10.3762/bjoc.13.106

• the modes of action of G-protein coupled receptors (GPCRs). In this field, MD simulations are unusually important as, because of the difficult experimental situation, they often offer the only opportunity to determine structural and mechanistic features in atomistic detail. Modern combinations of soft

• with what is already available, it reuses successful designs again and again in slightly modified forms. This is the case for the most common means of communicating across cell walls in eukaryotes, G-protein coupled receptors (GPCRs). GPCRs span the cell membrane and generally complex switching ligands

Interactions between cyclodextrins and cellular components: Towards greener medical applications?

• Loïc Leclercq

Beilstein J. Org. Chem. 2016, 12, 2644–2662, doi:10.3762/bjoc.12.261

• times sweeter than sucrose. Thaumatin has been shown to bind to G-protein-coupled receptors (GPCRs) which are transmembrane proteins, responsible for signal transduction. Therefore, the interaction of CDs with thaumatin could be used to modify the interaction of thaumatin with GPCRs and to modify its

Synthesis of constrained analogues of tryptophan

• Elisabetta Rossi,
• Valentina Pirovano,
• Marco Negrato,
• Giorgio Abbiati and
• Monica Dell’Acqua

Beilstein J. Org. Chem. 2015, 11, 1997–2006, doi:10.3762/bjoc.11.216

• to the identification of new dual NK1/NK2 antagonists [12], as shown in Figure 2 (B). In 2003, the pharmaceutical company Zentaris patented a series of tetrahydrocarbazole derivatives as ligands for G-protein-coupled receptors (GPCR), and in particular as antagonists of the gonadotropin-releasing

Application of cyclic phosphonamide reagents in the total synthesis of natural products and biologically active molecules

• Thilo Focken and
• Stephen Hanessian

Beilstein J. Org. Chem. 2014, 10, 1848–1877, doi:10.3762/bjoc.10.195

• confirming the proposed stereochemistry [49]. Glutamate metabotropic receptor agonists (2000, 2007) The metabotropic glutamate receptors (mGluRs) are members of the vast family of G-protein coupled receptors which are expressed throughout the central nervous system. They consist of at least eight sub-types

Asymmetric Ugi 3CR on isatin-derived ketimine: synthesis of chiral 3,3-disubstituted 3-aminooxindole derivatives

• Giordano Lesma,
• Fiorella Meneghetti,
• Alessandro Sacchetti,
• Mattia Stucchi and
• Alessandra Silvani

Beilstein J. Org. Chem. 2014, 10, 1383–1389, doi:10.3762/bjoc.10.141

• additions or spiroannulation [2][3]. Oxindoles represent a common structural element in various natural products and biologically active compounds. Diverse oxindole derivatives act as non-peptide scaffolds [4] in peptidomimetic chemistry, either as enzyme inhibitors or as ligands of G-protein-coupled

• receptors [5]. In particular, 3,3-disubstituted 3-amino-2-oxindoles are present in several drug candidates. They exhibit various types of bioactivity, such as the potent gastrin/CCK-B receptor antagonist I [6], the vasopressin VIb receptor antagonist II [7][8], the CRTH2 (DP2) receptor antagonist

Automated solid-phase peptide synthesis to obtain therapeutic peptides

• Veronika Mäde,
• Sylvia Els-Heindl and
• Annette G. Beck-Sickinger

Beilstein J. Org. Chem. 2014, 10, 1197–1212, doi:10.3762/bjoc.10.118

• as food intake, energy homeostasis, cancer, cell proliferation, blood pressure and epilepsy [122][123]. Those effects are mediated by four distinct G protein-coupled receptors (Y1, Y2, Y4, Y5) that are expressed in central and/or peripheral tissues. SPPS offers a great opportunity to synthetically

Total synthesis of the endogenous inflammation resolving lipid resolvin D2 using a common lynchpin

• John Li,
• May May Leong,
• Alastair Stewart and
• Mark A. Rizzacasa

Beilstein J. Org. Chem. 2013, 9, 2762–2766, doi:10.3762/bjoc.9.310

• the FPR2 and GPR32 types of G-Protein-coupled receptors, the receptor(s) for RvD2 remain to be identified. Identification of the receptors mediating the combined anti-inflammatory and antimicrobial actions would facilitate efforts to identify ligands that have better drug-like properties than RvD2 or

An overview of the synthetic routes to the best selling drugs containing 6-membered heterocycles

• Marcus Baumann and
• Ian R. Baxendale

Beilstein J. Org. Chem. 2013, 9, 2265–2319, doi:10.3762/bjoc.9.265

Synthesis of the calcilytic ligand NPS 2143

• Henrik Johansson,
• Thomas Cailly,
• Alex Rojas Bie Thomsen,
• Hans Bräuner-Osborne and
• Daniel Sejer Pedersen

Beilstein J. Org. Chem. 2013, 9, 1383–1387, doi:10.3762/bjoc.9.154

• optical purity (er > 99:1) as demonstrated by chiral HPLC and the pharmacological profile for (R)-3 is in full accordance with that reported in the literature. Keywords: epoxides; GPCR; NPS 2143; nucleophilic aromatic substitution; pyrylium chemistry; Introduction The first G-protein-coupled receptors

Development of peptidomimetic ligands of Pro-Leu-Gly-NH₂ as allosteric modulators of the dopamine D₂ receptor

• Swapna Bhagwanth,
• Ram K. Mishra and
• Rodney L. Johnson

Beilstein J. Org. Chem. 2013, 9, 204–214, doi:10.3762/bjoc.9.24

• to identify molecules that are able to act as allosteric regulators of specific G protein-coupled receptors (GPCRs), since such ligands have the potential to serve as novel therapeutic agents that are able to provide a means of fine-tuning receptor responses to orthosteric agonists or antagonists. In

• -protein coupled receptors, this work illustrates the potential value of receptor modulation as a means of perturbing traditional ligand–receptor interaction [62][63] and it demonstrates that this can be a successful platform for understanding biological function with peptidomimetic probes. PLG

• dopaminergic neurotransmission. This knowledge will be useful in developing novel central nervous system (CNS) drugs to treat conditions in which the dopamine receptors are directly implicated (i.e., Parkinson’s disease, schizophrenia, Gilles de la Tourette syndrome, etc.) [59][60][61]. Within the context of G

Pd/C- Mediated synthesis of indoles in water

• Mohosin Layek,
• Udaya Lakshmi,
• Dipak Kalita,
• Deepak K. Barange,
• Aminul Islam,
• K. Mukkanti and
• Manojit Pal

Beilstein J. Org. Chem. 2009, 5, No. 46, doi:10.3762/bjoc.5.46

• in coagulation [2][3], antagonists of G-protein-coupled receptors [4][5], anti-angiogenic compounds [6] and inhibitors of endothelinconverting-enzyme [7]. 5-Alkyl substituted indoles e.g. naratriptan (B, Figure 1) on the other hand have been reported as a 5-HT1B/1D receptor agonists for the potential